Canada markets closed

Serina Therapeutics, Inc. (SER)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
8.14-0.66 (-7.50%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
Total Revenue
0
500
3,039
Operating Expenses
Research Development
1,567
1,573
3,799
Selling General and Administrative
1,821
1,289
1,298
Total Operating Expenses
3,259
2,770
4,671
Operating Income or Loss
-3,259
-2,270
-1,632
Interest Expense
297.581
15.878
3.094
Total Other Income/Expenses Net
4,662
-397.619
359.04
Income Before Tax
1,194
-2,682
-1,265
Income from Continuing Operations
1,194
-2,682
-1,265
Net Income
1,194
-2,682
-1,265
Net Income available to common shareholders
1,194
-2,682
-1,265
Basic EPS
0.48
-1.07
-0.51
Diluted EPS
0.48
-1.07
-0.51
Basic Average Shares
2,501
2,501
2,501
Diluted Average Shares
2,501
2,501
2,501